Presentation is loading. Please wait.

Presentation is loading. Please wait.

Volume 75, Issue 4, Pages (April 2019)

Similar presentations


Presentation on theme: "Volume 75, Issue 4, Pages (April 2019)"— Presentation transcript:

1 Volume 75, Issue 4, Pages 570-578 (April 2019)
Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance- guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study  Marloes van der Leest, Erik Cornel, Bas Israël, Rianne Hendriks, Anwar R. Padhani, Martijn Hoogenboom, Patrik Zamecnik, Dirk Bakker, Anglita Yanti Setiasti, Jeroen Veltman, Huib van den Hout, Hans van der Lelij, Inge van Oort, Sjoerd Klaver, Frans Debruyne, Michiel Sedelaar, Gerjon Hannink, Maroeska Rovers, Christina Hulsbergen-van de Kaa, Jelle O. Barentsz  European Urology  Volume 75, Issue 4, Pages (April 2019) DOI: /j.eururo Copyright © 2018 The Authors Terms and Conditions

2 Fig. 1 Flow diagram of study design and participants. mpMRI=multiparametric magnetic resonance imaging; MRGB=magnetic resonance-guided biopsy; PI-RADS=Prostate Imaging Reporting and Data System; PSA=prostate-specific antigen; TRUSGB=transrectal ultrasound-guided biopsy. European Urology  , DOI: ( /j.eururo ) Copyright © 2018 The Authors Terms and Conditions

3 Fig. 2 Prostate cancer detection, overdetection, and underdetection for (non)suspicious mpMRI. Definition of csPCa: grade group ≥2 (Gleason score ≥3+4). Percentages may not total 100 because of rounding. csPCa=clinically significant prostate cancer; insignPCa=clinically insignificant prostate cancer; MRGB=magnetic resonance-guided biopsy; NA=not applicable; PCa=prostate cancer; PI-RADS=Prostate Imaging Reporting and Data System; TRUSGB=transrectal ultrasound-guided biopsy. Definitions of csPCa: *underdetection: csPCa not detected by biopsy strategy including cancers detected in 1-yr follow-up; **overdetection: insignPCa detected by biopsy strategy; ***net reduction of insignPCa in MRGB+TRUSGB due to shift from insignPCa to csPCa (underdetection); 11 additional cases of insignificant PCa were detected at TRUSGB where MRGB yielded no PCa. European Urology  , DOI: ( /j.eururo ) Copyright © 2018 The Authors Terms and Conditions


Download ppt "Volume 75, Issue 4, Pages (April 2019)"

Similar presentations


Ads by Google